Home › NDC Lookup › Labelers › Nuvaila Limited

Nuvaila Limited NDCs and Package Codes

This page lists NDC package records associated with labeler code 84612 (Nuvaila Limited) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

15
Package NDCs
16
Products
16
Active listings
0
Discontinued
3
Ingredients
0
Therapeutic classes
3
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
adalimumab-atto 8
ustekinumab-auub 7
Mesalamine 1
By dosage form
INJECTION 8
INJECTION, SOLUTION 7
TABLET, DELAYED RELEASE 1

Browse records — 16 products

Drug / product Billing NDC NADAC / unit Status
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Nuvaila · NDC 84612-0482-01 · 1 SYRINGE in 1 CARTON (84612-482-01) / .4 mL in 1 SYRINGE 84612-0482-01 — On market View →
AMJEVITA adalimumab-atto 20 mg/.2mL INJECTION Nuvaila · NDC 84612-0399-01 · 1 SYRINGE in 1 CARTON (84612-399-01) / .2 mL in 1 SYRINGE 84612-0399-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Nuvaila · NDC 84612-0479-01 · 1 SYRINGE in 1 CARTON (84612-479-01) / .4 mL in 1 SYRINGE 84612-0479-01 — On market View →
AMJEVITA adalimumab-atto 80 mg/.8mL INJECTION Nuvaila · NDC 84612-0481-01 · 1 SYRINGE in 1 CARTON (84612-481-01) / .8 mL in 1 SYRINGE 84612-0481-01 — On market View →
AMJEVITA adalimumab-atto 20 mg/.2mL INJECTION Nuvaila · NDC 84612-0399-01 · 1 SYRINGE in 1 CARTON (84612-399-01) / .2 mL in 1 SYRINGE 84612-0399-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Nuvaila · NDC 84612-0482-01 · 1 SYRINGE in 1 CARTON (84612-482-01) / .4 mL in 1 SYRINGE 84612-0482-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Nuvaila · NDC 84612-0479-01 · 1 SYRINGE in 1 CARTON (84612-479-01) / .4 mL in 1 SYRINGE 84612-0479-01 — On market View →
AMJEVITA adalimumab-atto 80 mg/.8mL INJECTION Nuvaila · NDC 84612-0481-01 · 1 SYRINGE in 1 CARTON (84612-481-01) / .8 mL in 1 SYRINGE 84612-0481-01 — On market View →
Mesalamine 1.2 g/1 TABLET, DELAYED RELEASE Nuvaila · NDC 84612-0175-13 · 120 TABLET, DELAYED RELEASE in 1 BOTTLE (84612-175-13) 84612-0175-13 — On market View →
WEZLANA ustekinumab-auub 45 mg/.5mL INJECTION, SOLUTION Nuvaila · NDC 84612-0055-01 · 1 VIAL in 1 CARTON (84612-055-01) / .5 mL in 1 VIAL 84612-0055-01 — On market View →
WEZLANA ustekinumab-auub 45 mg/.5mL INJECTION, SOLUTION Nuvaila · NDC 84612-0076-01 · 1 SYRINGE in 1 CARTON (84612-076-01) / .5 mL in 1 SYRINGE 84612-0076-01 — On market View →
WEZLANA ustekinumab-auub 90 mg/mL INJECTION, SOLUTION Nuvaila · NDC 84612-0089-01 · 1 SYRINGE in 1 CARTON (84612-089-01) / 1 mL in 1 SYRINGE 84612-0089-01 — On market View →
WEZLANA ustekinumab-auub 45 mg/.5mL INJECTION, SOLUTION Nuvaila · NDC 84612-0855-01 · 1 VIAL in 1 CARTON (84612-855-01) / .5 mL in 1 VIAL 84612-0855-01 — On market View →
WEZLANA ustekinumab-auub 130 mg/26mL INJECTION, SOLUTION Nuvaila · NDC 84612-0066-01 · Q5138 · 1 VIAL in 1 CARTON (84612-066-01) / 26 mL in 1 VIAL 84612-0066-01 — On market View →
WEZLANA ustekinumab-auub 90 mg/mL INJECTION, SOLUTION Nuvaila · NDC 84612-0889-01 · 1 SYRINGE in 1 CARTON (84612-889-01) / 1 mL in 1 SYRINGE 84612-0889-01 — On market View →
WEZLANA ustekinumab-auub 45 mg/.5mL INJECTION, SOLUTION Nuvaila · NDC 84612-0876-01 · 1 SYRINGE in 1 CARTON (84612-876-01) / .5 mL in 1 SYRINGE 84612-0876-01 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.